Trial watch: NeuroSearch's dopaminergic stabilizer improves movement disorders in Huntington's disease.
D017326:Clinical Trials, Phase III as Topic; D004298:Dopamine / Q000378:metabolism*; D004353:Drug Evaluation, Preclinical; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy* / Q000503:physiopathology; D009069:Movement Disorders / Q000188:drug therapy / Q000209:etiology; D010880:Piperidines / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use
D010880:Piperidines; C483720:pridopidine; D004298:Dopamine